Vaishali Pharma Limited (NSE:VAISHALI)
India
· Delayed Price · Currency is INR 11.60
+0.06 (0.52%)
Jun 30, 2025, 3:29 PM IST
Vaishali Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 978.82 | 862.8 | 696.63 | 758.21 | 537.74 | Upgrade
|
Other Revenue | 43.49 | - | - | - | - | Upgrade
|
| 1,022 | 862.8 | 696.63 | 758.21 | 537.74 | Upgrade
| |
Revenue Growth (YoY) | 18.49% | 23.85% | -8.12% | 41.00% | -10.51% | Upgrade
|
Cost of Revenue | 856.74 | 744.37 | 547 | 635.17 | 461.7 | Upgrade
|
Gross Profit | 165.57 | 118.43 | 149.63 | 123.04 | 76.04 | Upgrade
|
Selling, General & Admin | 25.79 | 28.11 | 26.1 | 22.13 | 19.39 | Upgrade
|
Other Operating Expenses | 106.82 | 22.72 | 29.75 | 32.06 | 11.97 | Upgrade
|
Operating Expenses | 137.48 | 106.83 | 60.89 | 58.75 | 53.83 | Upgrade
|
Operating Income | 28.09 | 11.6 | 88.74 | 64.29 | 22.21 | Upgrade
|
Interest Expense | -15.83 | -22.67 | -22.56 | -24.89 | -26.26 | Upgrade
|
Interest & Investment Income | - | 13.92 | 12.55 | 12.98 | 12.58 | Upgrade
|
Currency Exchange Gain (Loss) | - | 1.71 | 5.41 | 4.43 | 3.98 | Upgrade
|
Other Non Operating Income (Expenses) | - | 4.7 | 4.33 | 0.47 | 1.52 | Upgrade
|
EBT Excluding Unusual Items | 12.26 | 9.26 | 88.46 | 57.28 | 14.05 | Upgrade
|
Pretax Income | 12.26 | 9.26 | 88.46 | 57.28 | 14.05 | Upgrade
|
Income Tax Expense | 4.08 | 2.07 | 22.43 | 17.05 | 3.58 | Upgrade
|
Net Income | 8.17 | 7.19 | 66.04 | 40.24 | 10.46 | Upgrade
|
Net Income to Common | 8.17 | 7.19 | 66.04 | 40.24 | 10.46 | Upgrade
|
Net Income Growth | 13.69% | -89.11% | 64.12% | 284.58% | 3091.34% | Upgrade
|
Shares Outstanding (Basic) | 26 | 106 | 105 | 105 | 105 | Upgrade
|
Shares Outstanding (Diluted) | 26 | 112 | 112 | 105 | 105 | Upgrade
|
Shares Change (YoY) | -76.53% | 0.53% | 5.95% | - | - | Upgrade
|
EPS (Basic) | 0.31 | 0.07 | 0.63 | 0.38 | 0.10 | Upgrade
|
EPS (Diluted) | 0.31 | 0.06 | 0.59 | 0.38 | 0.10 | Upgrade
|
EPS Growth | 384.38% | -89.17% | 54.90% | 284.58% | 3091.96% | Upgrade
|
Free Cash Flow | -183.43 | 6.96 | 7.82 | 4.54 | 18.85 | Upgrade
|
Free Cash Flow Per Share | -6.96 | 0.06 | 0.07 | 0.04 | 0.18 | Upgrade
|
Gross Margin | 16.20% | 13.73% | 21.48% | 16.23% | 14.14% | Upgrade
|
Operating Margin | 2.75% | 1.34% | 12.74% | 8.48% | 4.13% | Upgrade
|
Profit Margin | 0.80% | 0.83% | 9.48% | 5.31% | 1.95% | Upgrade
|
Free Cash Flow Margin | -17.94% | 0.81% | 1.12% | 0.60% | 3.51% | Upgrade
|
EBITDA | 32.95 | 14.16 | 91.37 | 66.8 | 24.48 | Upgrade
|
EBITDA Margin | 3.22% | 1.64% | 13.11% | 8.81% | 4.55% | Upgrade
|
D&A For EBITDA | 4.87 | 2.57 | 2.63 | 2.51 | 2.26 | Upgrade
|
EBIT | 28.09 | 11.6 | 88.74 | 64.29 | 22.21 | Upgrade
|
EBIT Margin | 2.75% | 1.34% | 12.74% | 8.48% | 4.13% | Upgrade
|
Effective Tax Rate | 33.32% | 22.37% | 25.35% | 29.76% | 25.51% | Upgrade
|
Revenue as Reported | 1,022 | 883.13 | 718.92 | 776.09 | 555.83 | Upgrade
|
Advertising Expenses | - | 4.86 | 5.29 | 0.86 | 0.66 | Upgrade
|
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.